Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype

Leukemia. 2006 Sep;20(9):1644-6. doi: 10.1038/sj.leu.2404294. Epub 2006 Jun 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Humans
  • Karyotyping
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / genetics
  • Leukemia, Myeloid / surgery*
  • Mutation
  • Nuclear Proteins / genetics*
  • Nucleophosmin
  • Polymerase Chain Reaction

Substances

  • NPM1 protein, human
  • Nuclear Proteins
  • Nucleophosmin